Amneal Pharmaceuticals, Inc.
AMRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723128
In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 160 | 1 | 155 | −4 |
| Shares | 99.9M | 4.19K | 100.4M | +443.8K (+0.4%) |
| Value | $511.6M | $21.0K | $535.3M | +$23.7M (+4.6%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SG Americas Securities, LLC | 39,120 | $209.0K | 0.00% |
| HRT Financial LP | 37,933 | $202.0K | 0.00% |
| Virtu Financial LLC | 34,927 | $187.0K | 0.02% |
| Jane Street Group, LLC | 31,622 | $169.0K | 0.00% |
| Kestra Advisory Services, LLC | 26,884 | $144.0K | 0.00% |
| Centiva Capital, LP | 22,752 | $121.0K | 0.01% |
| Stifel Financial Corp | 19,863 | $106.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 18,042 | $96.0K | 0.00% |
| Jump Financial, LLC | 16,900 | $90.0K | 0.01% |
| Lazard Asset Management LLC | 10,340 | $55.0K | 0.00% |
| Harel Insurance Investments & Financial Services Ltd. | 5,409 | $29.0K | 0.00% |
| Smith Group Asset Management, LLC | 4,190 | $22.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 619 | $3.00K | 0.00% |
| Community Bank, N.A. | 200 | $1.00K | 0.00% |
| Berman Capital Advisors, LLC | 329 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 84 | $0 | 0.00% |
| Meridian Wealth Partners, LLC | 25 | $0 | 0.00% |
Sold out (21)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Magnetar Financial LLC | 119,317 | $611.0K |
| Gsa Capital Partners LLP | 111,200 | $569.0K |
| Alps Advisors Inc | 50,325 | $258.0K |
| CWM Advisors, LLC | 44,748 | $229.0K |
| ExodusPoint Capital Management, LP | 42,032 | $215.0K |
| Quadrature Capital Ltd | 37,211 | $191.0K |
| PDT Partners, LLC | 36,020 | $184.0K |
| Qube Research & Technologies Ltd | 34,780 | $178.0K |
| Occudo Quantitative Strategies LP | 31,893 | $163.0K |
| Boothbay Fund Management, LLC | 24,239 | $124.0K |
| Blueshift Asset Management, LLC | 23,739 | $122.0K |
| Ergoteles LLC | 19,300 | $99.0K |
| Fox Run Management, L.L.C. | 14,184 | $73.0K |
| Winton Group Ltd | 13,492 | $69.0K |
| Profund Advisors LLC | 11,333 | $59.0K |
| Highland Capital Management, LLC | 10,980 | $56.0K |
| Qtron Investments LLC | 10,861 | $56.0K |
| Strategic Blueprint, LLC | 3,000 | $15.0K |
| Advisory Services Network, LLC | 1,000 | $5.00K |
| Northwestern Mutual Wealth Management Co | 1 | $0 |
| O'Shaughnessy Asset Management, LLC | 61 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Smith Asset Management Group LP | 4,190 | $21.0K |